Zai Lab Ltd (ZLAB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.07B
Last updated: Nov 17, 2026 at 11:06 AM ET
Zai Lab Ltd (ZLAB) Competitors
The companies most similar to Zai Lab are Legend Biotech (LEGN), Xencor (XNCR) and Telix Pharmaceuticals (TLX). By market cap, Zai Lab ranks 6th of the 13 companies on this page; Crispr Therapeutics AG (CRSP) is the largest at $4.10B.
Peer Comparison
ZLAB's ROIC of -23.6% is above the peer median of -29.0%, and its revenue growth of -6.8% is below the median of 16.2%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Zai Lab (ZLAB) | $3.07B | N/A | 6.0x | -44.9% | -23.6% | -6.8% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Xencor Inc (XNCR) | $2.78B | N/A | 13.5x | -58.8% | -17.3% | 454.9% | 0.00% |
| Telix Pharmaceuticals Limited (TLX) | $3.14B | N/A | 5.3x | 3.8% | -0.7% | 22.3% | 0.00% |
| Zenas BioPharma, Inc. Common Stock (ZBIO) | $1.90B | N/A | 168.0x | 0.0% | -104.3% | -100.0% | 0.00% |
| Ideaya Biosciences Inc (IDYA) | $3.08B | N/A | 85.5x | 0.0% | N/A | -95.1% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Maravai Lifesciences Holdings Inc (MRVI) | $1.96B | N/A | 5.2x | -30.8% | -28.3% | 10.1% | 0.00% |
| Vir Biotechnology Inc (VIR) | $1.71B | N/A | 5.4x | -61.0% | N/A | 19582.0% | 0.00% |
| Disc Medicine Inc. (IRON) | $3.64B | N/A | N/A | 0.0% | -40.0% | 0.0% | 0.00% |
| Arcus Biosciences Inc (RCUS) | $2.51B | N/A | 21.5x | 0.0% | -75.9% | -65.4% | 0.00% |
| Vericel Corp Ord (VCEL) | $2.91B | 89.8x | 9.1x | 10.3% | N/A | 26.5% | 0.00% |
| Crispr Therapeutics AG (CRSP) | $4.10B | N/A | 155.2x | 0.0% | -20.3% | 1325.0% | 0.00% |
| Peer median | $2.84B | 178.2x | 13.5x | 0.0% | -29.0% | 16.2% | 0.00% |
Similar Companies
These are the 12 companies most similar to Zai Lab, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Xencor Inc (XNCR) | Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed... | XNCR competitors |
| Telix Pharmaceuticals Limited (TLX) | Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic... | |
| Zenas BioPharma, Inc. Common Stock (ZBIO) | Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based... | ZBIO competitors |
| Ideaya Biosciences Inc (IDYA) | IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality... | IDYA competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Maravai Lifesciences Holdings Inc (MRVI) | Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines... | MRVI competitors |
| Vir Biotechnology Inc (VIR) | Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. | VIR competitors |
| Disc Medicine Inc. (IRON) | Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development... | IRON competitors |
| Arcus Biosciences Inc (RCUS) | Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. | RCUS competitors |
| Vericel Corp Ord (VCEL) | Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures... | VCEL competitors |
| Crispr Therapeutics AG (CRSP) | CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. | CRSP competitors |
Frequently Asked Questions About ZLAB
Who are Zai Lab's main competitors?
The companies most similar to Zai Lab include Legend Biotech (LEGN), Xencor (XNCR), Telix Pharmaceuticals (TLX), Zenas BioPharma, Inc. Common Stock (ZBIO) and Ideaya Biosciences (IDYA), listed from the closest match.
Who is Zai Lab's biggest competitor?
Crispr Therapeutics AG (CRSP) is the largest of the similar companies at $4.10B; Legend Biotech (LEGN) is the closest match by business profile, size, sector and industry.
How does ZLAB stock compare with its competitors?
ZLAB's P/S is 6.0x against a peer median of 13.5x; its net margin is -44.9% against a peer median of 0.0%.
Which of Zai Lab's competitors pays a higher dividend?
Zai Lab pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Zai Lab bigger than its competitors?
No. Zai Lab is 6th by market cap among the 13 companies on this page; the largest is Crispr Therapeutics AG (CRSP) at $4.10B.
ZLAB pages: Overview, Earnings, Forecast, Financials, Competitors